Miljöpåverkan
Miljöinformationen för estradiol är framtagen av företaget Bayer för Allurene®, Angemin®, Climara, Climara®, Climodien®, Progynon®, Qlaira
Miljörisk:
Användning av estradiol har bedömts medföra medelhög risk för miljöpåverkan.
Nedbrytning:
Estradiol bryts ned långsamt i miljön.
Bioackumulering:
Estradiol har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
Currently, estradiol is marketed in Sweden as estradiol hemihydrate and estradiol valerate. Estradiol is the active pharmaceutical ingredient (API) and marketed volumes need to be adjusted to this moiety for PEC calculation.
Estradiol varieties |
Molecular weight |
Conversion factor |
Sale volume (2022) |
API amount (2022) |
Estradiol |
272.4 g/Mol |
1.00 |
--- |
--- |
Estradiol hemihydrate* |
562.8 g/Mol |
0.97 |
28.56 |
27.70 |
Estradiol valerate |
356.5 g/Mol |
0.76 |
16.87 |
12.82 |
Total sale volume API (kg/year) |
40.52 |
|||
* contains two moieties of estradiol |
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R) = 0.00102 μg/L
Where:
A = 40.52 kg (total sold amount API in Sweden year 2022, data from IQVIA / LIF
R = 81.69 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)
P = number of inhabitants in Sweden = 10 *106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference I)
D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference I)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies*
Algae (green algae, Desmodesmus subspicatus):
NOEC 72 hours (growth rate) ≥ 3100 μg/L, ErC50 72 hours (growth rate) > 3100 μg/L. Guideline OECD 201. (Reference II)
Crustacean (waterflea, Daphnia magna):
Chronic toxicity
NOEC 21 days (reproduction) ≥ 139 μg/L. Guideline FDA TAD 4.09. (Reference III)
Fish (rainbow trout, Oncorhynchus mykiss):
Acute toxicity
LC50 96 hours (survival) ≥ 500 μg/L. Guideline FDA TAD 4.11. (Reference IV)
Fish (fathead minnow, Pimephales promelas):
Chronic toxicity
EC10 56 days (weight) = 0.008 μg/L. Guideline EPA FIFRA Subdev. E, 72-5. (Reference V)
Fish (Japanese rice fish, Oryzias latipes):
Chronic toxicity
Besides the OECD studies complying with GLP documentation requirements, there is a published fish full life-cycle study, that was conducted with the Japanese rice fish (Oryzias latipes). The test setup is exploratory but the publication was considered sufficiently reliable for derivation of the environmental quality standard (EQS) and therefore is included here. The study started with fish embryos 12 hours after fertilization and continued for up to 101 days including filial fish generation (spawned at day 98, 99, and 100) and assessed various endpoints. Fish were exposed continuously (flow-through system) at 0.939, 2.86, 8.66, 27.9, and 92.4 ng/L. Most endpoints showed no concentration-response related effects of estradiol. However, sex differentiation, induced vitellogenin (VTG; yolk protein), and reproductive impairment were observed with concentration-response relationship in the parent fish generation, coming up with a NOEC of 2.86 ng/L. There were no effects in the filial fish generation at concentrations below 8.66 ng/L.
NOEC 101 days (fertility) = 2.86 ng/L = 0.00286 μg/L. Fish full life-cycle exploratory study. (Reference VI)
The PNEC was calculated by division of the lowest effect level (NOEC) of the most sensitive taxonomic group considering an appropriate assessment factor (AF). The most sensitive taxonomic group were fish and the lowest effect level was reported as NOEC = 0.00286 µg/L. The regulatory default standard AF of 10 was used, which is applicable when there are chronic aquatic toxicity studies representing the three trophic levels (algae, crustaceans, and fish).
PNEC = 0.00286 µg/L / 10 = 0.000286 µg/L
Environmental risk classification (PEC/PNEC ratio)
The risk quotient PEC/PNEC was calculated as 0.00102 µg/L / 0.000286 µg/L = 3.57.
Justification of chosen environmental risk phrase:
A risk quotient above 10 qualifies for the phrase “Use of estradiol has been considered to result in moderate environmental risk.”.
Degradation
Biotic degradation
Ready degradability:
Ready biodegradation of estradiol was determined in three studies, one in accordance with OECD 310B and two according to FDA TAD 3.11. The studies reported more than 60 % biodegradation of estradiol in 28 days. Guideline OECD 301. (Reference VII, VIII, IX)
Abiotic degradation
Hydrolysis:
This study reported that estradiol is stable. Guideline FDA TAD 3.09. (Reference X)
SimpleTreat modelling – elimination in sewage treatment plants
The SimpleTreat model (v4.1) was used to estimate the fraction of estradiol that is retained in sewage treatment plant and does not enter the surface water compartment. The calculation is based on experimental physico-chemical data of estradiol. Molecular weight: 272.4 g/mol, octanol-water partition coefficient (KOW): 4.03, vapour pressure: 0.00000003 Pa at 25 °C, water solubility: 1.7 mg/L at 20 °C, organic carbon partition coefficient (KOC): 2511 and biodegradation: readily biodegradable, failing 10-day window. (Reference VIII, XI, XII, XIII)
SimpleTreat calculated the release to surface water after sewage treatment as 18.31 %, i.e., 81.69 % are eliminated by ready biodegradation or binding to sludge. The PEC calculation was refined taking account of this elimination.
Justification of chosen degradation phrase:
The high ready biodegradation and elimination in sewage treatment plants qualifies for the phrase “Estradiol is slowly degraded in the environment.”.
Bioaccumulation
Partitioning coefficient:
The log Dow was reported as 4.03. Guideline FDA TAD 3.02. (Reference XI)
Bioconcentration factor (BCF):
In addition, a bioaccumulation study according to OECD TG 305 was conducted. 20 fish (Lepomis macrochirus) were exposed to14C labeled estradiol as well as 40 fish in the tap water control and exposed for an uptake period of 22 days, followed by 8 days depuration. There were 2 replicates per treatment and 1 for the control.
The test substance solution was delivered continuously to the tanks. The nominal concentration of estradiol in the water was 276 ng/L. The concentration of the test substance in the fish and in the water was determined in the uptake and depuration phase of the test. The 14C concentration in the fish was analyzed by liquid scintillation after oxidative degradation of the fish in samples taken on day 4, 6, 10, 14, 21, 24, 26, and 30. The 14C concentration in the water was analyzed by liquid scintillation in samples taken at the same time points. The bioconcentration factor in fish (BCFss) was calculated as the ratio of the mean values of the 14C concentration in fish and in water.
The BCFss was 108.8 (normalized to 5 % lipid: 71.58). The uptake rate constant (k1) was 1.1, the depuration rate constant (k2) was -2.2. The DT50 for depuration was determined with 3.2 days, indicating a rapid turnover of estradiol. This finding could be expected, since estradiol is an endogenous hormone metabolized rapidly during normal physiological processes.
The study reported a BCF of 71.58. Guideline OECD 305. (Reference XIV)
Justification of chosen bioaccumulation phrase:
As the BCF was < 500 estradiol is not considered bioaccumulative which qualifies for the phrase “Estradiol has low potential for bioaccumulation.”.
Excretion (metabolism)
Estradiol valerate are readily cleaved into estradiol and valeric acid. Estradiol undergoes the same metabolic pathways as endogenous estrogen, i.e. it is further metabolized into the major metabolites estrone, estriol, estrone sulfate and estrone glucuronide.
Despite the high metabolization this was not considered for refinement of the PEC calculation, as the primary metabolites are estrogenic as well, although to a lesser extent (Reference XV, XVI, XVII)
References
-
Guidance on information requirements and Chemical Safety Assessment Chapter R.16: Environmental exposure assessment. V3.0, Feb. 2016.
-
Growth inhibition test with estradiol (ZK 5018) on the green algae Desmodesmus subspicatus. Experimental Toxicology, Schering AG, study no. TXST20020260, report no. A30506 (2006)
-
Reproduction and chronic immobilization study of estradiol in Daphnia magna. Experimental Toxicology, Schering AG, study no. TX96156, report no. AQ94 (2001)
-
Acute toxicity of 17β-estradiol with the rainbow trout. Experimental Toxicology, Schering AG, study no. TX95070, report no. A05662 (2001)
-
Evaluation of the reports entitled: [14C]Ethinylestradiol – Early life-stage toxicity test with fathead minnow (Pimephales promelas). Experimental Toxicology, Schering AG, study no. TXST19960143, report no. No. B945 (1999)
-
Seki M, Yokota H, Maeda M, Kobayashi K. Fish full lifecycle testing for 17β-estradiol on medaka (Oryzias latipes). Environmental Toxicology and Chemistry 24, 1259-1266 (2005)
-
Study of aerobic biodegradability of estradiol. Experimental Toxicology, Schering AG, study no. TX95270, report no. A05658 (2001)
-
Study on the biodegradability of estradiol in the CO2-evolution test (Modified Sturm-Test). Experimental Toxicology, Schering AG, study no. TXST19970041, report no. A05659 (2001)
-
Study of aerobic biodegradability of estradiol. Experimental Toxicology, Schering AG, study no. TX96181, report no. A05814 (2001)
-
Estradiol/ZK 5018/Report on physicochemical properties/Rate of hydrolysis. General Physical Chemistry, Schering AG, study no. 0353, report no. N408 (2001)
-
Estradiol, ZK5018, Report on physicochemical properties, Water solubility, N-octanol/water partition coefficient. General Physical Chemistry, Schering AG, Berlin, report no. A02014.
-
Estradiol/ZK 5018/Report on physicochemical properties/ Vapour pressure. General Physical Chemistry, Schering AG, Berlin, study no. 0121, report no. M963EY10.
-
Estradiolhemihydrat/ ZK 5018/Report on physico-chemical properties/ Estimation of the adsorption coefficient (KOC) on soil and sewage sludge (HPLC method). Analytical Development Physical Chemistry, Schering AG, Berlin, study no. 07100160, report no. A39007.
-
Bioconcentration flow-through fish test with estradiol [BAY 86-5435 (14-C)]. Nonclinical Drug Safety, Bayer Schering Pharma AG, study no. TOXT7082197, report no. A52549 (2011)
-
Hobkirk, R., Mellor, J. D., Nilsen, M.: In vitro metabolism of 17β-estradiol by human liver tissue. Can. J. Biochem. 53, 903-906 (1975). (1.6.1.3.1 Hobkirk et al. 1975)
-
Lievertz, R.W.: Pharmacology and pharmacokinetics of estrogens. Am. J. Obstet. Gynecol. 156, 1289-1293 (1987). (1.6.1.3.1 Lievertz 1987)
-
Slaunwhite, R.W, Kirdani, R.Y., Sandberg A.A.: Metabolic aspects of estrogens in man. In: Greep, R. O., Astwood, E. B. (Eds.): Handbook of Physiology, Section 7: Endocrinology, Vol. 2, Female Reproductive Sytem, part 1, Chapter 21, American Physiology Society, Washington DC, 1973, pp. 485-523. (1.6.1.3.1 Slaunwhite et al. 1973)
Miljöinformationen för noretisteron är framtagen av företaget Bayer för Primolut®-Nor
Miljörisk:
Användning av noretisteron har bedömts medföra medelhög risk för miljöpåverkan.
Nedbrytning:
Noretisteron är potentiellt persistent.
Bioackumulering:
Noretisteron har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R) = 0.0018 μg/L
Where:
A = 13.03 kg (total sold amount API in Sweden year 2021, data from IQVIA / LIF)
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available
P = number of inhabitants in Sweden = 10 *106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference I)
D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference I)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies*
Algae (green algae, Desmodesmus subspicatus):
NOEC 72 hours (growth rate) = 0.013 mg/L, ErC50 72 hours (growth rate) = 0.51 mg/L. Guideline OECD 201. (Reference II)
Crustacean (waterflea, Daphnia magna):
Acute toxicity
EC50 48 hours (immobilization) > 4.6 mg/L. Guideline OECD 202. (Reference III)
Fish (zebrafish, Danio rerio):
Acute toxicity
LC50 96 hours (survival) > 5.03 mg/L. Guideline OECD 203. (Reference IV)
Chronic toxicity
NOEC 28 days (reproduction) = 0.005 μg/L. Non-standard test method. (Reference V)
The PNEC was calculated by division of the lowest effect level (NOEC) of the most sensitive taxonomic group considering an appropriate assessment factor (AF). There is no chronic study with daphnids but as norethisterone (acetate) is a hormone fish can be expected to be the most sensitive taxonomic group and the respective NOEC = 0.005 µg/L. The regulatory default standard AF of 10 was used, which is applicable when there are chronic aquatic toxicity studies representing the three trophic levels (algae, crustaceans, and fish).
PNEC = 0.005 µg/L / 10 = 0.0005 µg/L
Environmental risk classification (PEC/PNEC ratio)
The risk quotient PEC/PNEC was calculated with 0.0018 µg/L / 0.0005 µg/L = 3.57.
Justification of chosen environmental risk phrase:
A risk quotient between 1 and 10 qualifies for the phrase “Use of Norethisterone (acetate) has been considered to result in moderate environmental risk.”.
Degradation
Biotic degradation
Ready degradability:
The test substance was incubated in an aqueous solution including nutrients with activated sludge form a municipal sewage treatment plant for 30 days in a concentration of 10 mg carbon/L in triplicates. Additionally, sodium acetate as reference substance, a blank control and sodium acetate plus norethisterone e as toxicity control were tested. CO2 formation was measured on day 4, 7, 11, 14, 17, 23, 28 and 30. The study reported 0 % biodegradation of Norethisterone (acetate) in 28 days. Guideline OECD 301. (Reference VI)
Abiotic degradation
Hydrolysis:
Norethisterone (acetate) was determined to be stable at pH 5, 7, and 9. Guideline EEC, C.7. (Reference VII)
Justification of chosen degradation phrase:
Norethisterone (acetate) was not readily biodegradable, is hydrolytically stable and as there is no higher tier transformation study the half-life is considered to be DT50 > 120 d, which qualifies for the phrase “Norethisterone (acetate) is potentially persistent.”.
Bioaccumulation
Partitioning coefficient:
The log Dow was reported with 2.7 at pH 7. Guideline OECD 117. (Reference VIII)
Justification of chosen bioaccumulation phrase:
As the log Dow was < 4 Norethisterone (acetate) is not considered bioaccumulative which qualifies for the phrase “Norethisterone (acetate) has low potential for bioaccumulation.”.
References
-
Guidance on information requirements and Chemical Safety Assessment Chapter R.16: Environmental exposure assessment. V3.0, Feb. 2016.
-
Alga, growth inhibition test with norethisterone, Currenta GmbH & Co OHG, ownership: Bayer AG, report no. 2015/0057/04 (2016)
-
Acute immobilization of norethisterone e with Daphnia magna. Experimental Toxicology, Schering AG, study no. TX96099, report no. X211 (1997)
-
Fish, acute toxicity with norethisterone, Currenta GmbH & Co OHG, ownership: Bayer AG, report no. 2015/0057/03 (2016)
-
Paulos P, Runnalls TJ, Nallani G, La Point T, Scott AP, Sumpter JP, Huggett DB. (2010). Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic progestin, norethindrone. Aquat Toxicol 99:256–262.
-
Study on the biodegradability of norethisterone in the CO2- evolution test (modified Sturm-test). Experimental Toxicology, Schering AG, study no. TX96088, report no. X128 (1996)
-
Norethisterone/ZK5378/Report on physicochemical properties/estimation of the hydrolytic stability on the basis of hydrolytic behavior of structurally similar compounds. General Physical Chemistry, Schering AG, study no. APC194/00 (2000)
-
Norethisterone/ZK5378/Report on the partition coefficient. General Physical Chemistry, Schering AG, study no. APC132/95, report no. LJ0 (1995)